Effects of post-remission chemotherapy before allo-HSCT for acute myeloid leukemia during first complete remission: a meta-analysis Yangmin ZhuQingyan GaoFengkui Zhang Review Article 26 June 2018 Pages: 1519 - 1526
Copper deficiency anemia: review article Zin W. MyintThein H. OoHayder Saeed Review Article 29 June 2018 Pages: 1527 - 1534
Final analysis of the JALSG Ph+ALL202 study: tyrosine kinase inhibitor-combined chemotherapy for Ph+ALL Yoshihiro HattaShuichi MizutaTomoki Naoe Original Article Open access 24 April 2018 Pages: 1535 - 1545
The prognostic role of E2A-PBX1 expression detected by real-time quantitative reverse transcriptase polymerase chain reaction (RQ-PCR) in B cell acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation Yan HongXiaosu ZhaoXiaojun Huang Original Article 28 April 2018 Pages: 1547 - 1554
Acute promyelocytic leukemia cell adhesion to vascular endothelium is reduced by heparins Alfonso VignoliMarina MarchettiAnna Falanga Original Article 01 May 2018 Pages: 1555 - 1562
Distinctive CD8+ T cell and MHC class I signatures in polycythemia vera patients Elsa M. CardosoAndré J. EsgalhadoFernando A. Arosa Original Article 22 May 2018 Pages: 1563 - 1575
Ponatinib as second-line treatment in chronic phase chronic myeloid leukemia patients in real-life practice Massimo BrecciaElisabetta AbruzzeseRobin Foà Original Article 19 April 2018 Pages: 1577 - 1580
The WHO diagnostic criteria for polycythemia vera—role of red cell mass versus hemoglobin/hematocrit level and morphology Ljubomir JakovicMirjana GoticJürgen Thiele Original Article 01 May 2018 Pages: 1581 - 1590
Ruxolitinib for the treatment of inadequately controlled polycythemia vera without splenomegaly: 80-week follow-up from the RESPONSE-2 trial Martin GriesshammerGuray SaydamFrancesco Passamonti Original Article Open access 27 May 2018 Pages: 1591 - 1600
Allogeneic stem cell transplantation recipients requiring intensive care: time is of the essence Corentin OrvainFrancois BeloncleAline Tanguy-Schmidt Original Article 02 May 2018 Pages: 1601 - 1609
The prognostic value of positron emission tomography/computed tomography in rheumatoid arthritis patients with methotrexate-associated lymphoproliferative disorders Satoshi TakanashiTomonori NakazatoTakehiko Mori Original Article 30 April 2018 Pages: 1611 - 1618
Yttrium-90 ibritumomab tiuxetan (Zevalin) followed by BEAM (Z-BEAM) conditioning regimen and autologous stem cell transplantation (ASCT) in relapsed or refractory high-risk B-cell non-Hodgkin lymphoma (NHL): a single institution Italian experience Chiara CiochettoBarbara BottoUmberto Vitolo Original Article 16 April 2018 Pages: 1619 - 1626
Central nervous system localisation of chronic lymphocytic leukaemia, description of two very distinct cases and a review of the literature Nyanza K. L. M. TimmersJosanne S. de MaarSaskia K. Klein Original Article Open access 29 April 2018 Pages: 1627 - 1632
Incidence, predictive factors, management, and survival impact of atrial fibrillation in non-Hodgkin lymphoma Marc SorigueFrancisco Gual-CapllonchJuan-Manuel Sancho Original Article 04 May 2018 Pages: 1633 - 1640
Effectiveness of rituximab-containing treatment regimens in idiopathic multicentric Castleman disease Yujun DongLu ZhangJian Li Original Article 07 May 2018 Pages: 1641 - 1647
Sex-dependent association of circulating sex steroids and pituitary hormones with treatment-free survival in chronic lymphocytic leukemia patients Eric P. AllainKarin VenzlKatrina Vanura Original Article Open access 21 May 2018 Pages: 1649 - 1661
A higher percentage of cells with 13q deletion predicts worse outcome in Chinese patients with chronic lymphocytic leukemia carrying isolated 13q deletion Yuqing MiaoYi MiaoJian-Yong Li Original Article 07 May 2018 Pages: 1663 - 1669
Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival Eirini KatodritouMarie-Christine KyrtsonisEvangelos Terpos Original Article Open access 13 May 2018 Pages: 1671 - 1682
− 174 G>C IL-6 polymorphism and primary iron overload in male patients Walter F. TetzlaffTomás MeroñoFernando Brites Original Article 14 April 2018 Pages: 1683 - 1687
Efficacy of decitabine as hemoglobin F inducer in HbE/β-thalassemia Siddhesh Arun KalantriRudra RayMaitreyee Bhattacharyya Original Article 09 May 2018 Pages: 1689 - 1694
Ethnicity-specific impact of HLA I/II genotypes on the risk of inhibitor development: data from Korean patients with severe hemophilia A Hyun-Young KimJin-Hee ChoHee-Jin Kim Original Article 16 May 2018 Pages: 1695 - 1700
Low platelet count as risk factor for infections in patients with primary immune thrombocytopenia: a retrospective evaluation Mingming QuQiang LiuA. J. Gerard Jansen Original Article Open access 18 May 2018 Pages: 1701 - 1706
Utility and proposed algorithm of CSF flow cytometry in hematologic malignancies Bernard TawfikLarry BrownNavid Sadeghi Original Article 21 April 2018 Pages: 1707 - 1716
Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria C. CattaneoR. Di Blasion behalf of SEIFEM Group Original Article 28 April 2018 Pages: 1717 - 1726
Re-treatment versus extended treatment strategy of systemic bevacizumab in hereditary hemorrhagic telangiectasia: which is better? Narendranath EpperlaAriel KlemanPatrick Foy Letter to the Editor 14 April 2018 Pages: 1727 - 1729
SNP-based next-generation sequencing reveals low-level mixed chimerism after allogeneic hematopoietic stem cell transplantation Jieun KimIn Sik HwangSeung-Tae Lee Letter to the Editor 12 April 2018 Pages: 1731 - 1734
Mott cell interstitial nephritis revealing Waldenström macroglobulinaemia Anissa MoktefiCaroline DudreuilhPhilippe Rémy Letter to the Editor 08 April 2018 Pages: 1735 - 1736
Copper deficiency: a cause of misdiagnosis of myelodysplastic syndrome Ana VillalbaJulieta OsorioLeonor Senent Letter to the Editor 17 April 2018 Pages: 1737 - 1738
Successful full-dose DeVIC therapy in a patient with advanced-stage extranodal natural killer/T-cell lymphoma refractory to l-asparaginase Junko WatanabeShinichi MakitaKoji Izutsu Letter to the Editor 16 April 2018 Pages: 1739 - 1740
Massive hemolysis complicating acute granulomatous hepatitis Adrià CarpioAnna MerinoJavier Fernández Letter to the Editor 19 April 2018 Pages: 1741 - 1742
Correction to: The association of venous thromboembolism with survival in pediatric cancer patients: a population-based cohort study Zara ForbriggerStefan KuhleKetan Kulkarni Correction 27 June 2018 Pages: 1743 - 1743
Correction to: Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study Alexander EgleMichael SteurerRichard Greil Correction 23 June 2018 Pages: 1745 - 1745
Correction to: Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival Eirini KatodritouMarie-Christine KyrtsonisEvangelos Terpos Correction 26 June 2018 Pages: 1747 - 1747
